Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012340
Filing Date
2019-08-14
Accepted
2019-08-14 10:27:37
Documents
51
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 439458
2 ex31-1.htm EX-31.1 11630
3 ex31-2.htm EX-31.2 11652
4 ex32-1.htm EX-32.1 5888
5 ex32-2.htm EX-32.2 5767
  Complete submission text file 0001493152-19-012340.txt   3064711

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bblg-20190630.xml EX-101.INS 508526
7 XBRL SCHEMA FILE bblg-20190630.xsd EX-101.SCH 52888
8 XBRL CALCULATION FILE bblg-20190630_cal.xml EX-101.CAL 34565
9 XBRL DEFINITION FILE bblg-20190630_def.xml EX-101.DEF 161028
10 XBRL LABEL FILE bblg-20190630_lab.xml EX-101.LAB 336232
11 XBRL PRESENTATION FILE bblg-20190630_pre.xml EX-101.PRE 230272
Mailing Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803
Business Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803 (781) 552-4452
Bone Biologics Corp (Filer) CIK: 0001419554 (see all company filings)

EIN.: 421743430 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53078 | Film No.: 191023637
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies